Skip to main content
. 2024 Jul 14;8(16):4414–4422. doi: 10.1182/bloodadvances.2024012838

Figure 3.

Figure 3.

Kaplan-Meier curves for EFS and OS in the LEO cohort based on trial eligibility (POLARIX) among various racial/ethnic subgroups.